IPC
AMRI

Independent Portfolio Consultants’s Albany Molecular Research Inc AMRI Stock Holding History

Independent Portfolio Consultants’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-455
Closed -$9K – 821
2015
Q4 		$9K Hold
455
– – ﹤0.01% 722
2015
Q3 		$8K Buy
455
+325
+250% +$6.62K ﹤0.01% 747
2015
Q2 		$3K Buy
+130
New +$2.51K ﹤0.01% 821

Other funds holding AMRI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Independent Portfolio Consultants's AMRI Position: Q1 2016 in Review

Independent Portfolio Consultants sold out of Albany Molecular Research Inc (AMRI) in Q1 2016, closing a stake of 455 shares — an estimated $9K sold.

Independent Portfolio Consultants first reported a position in AMRI in Q2 2015 and held it in 3 quarters. The position peaked at $9K in Q4 2015. 141 funds tracked by Wall St. Rank hold AMRI as of Q1 2016.

  • Independent Portfolio Consultants reported no remaining Albany Molecular Research Inc position as of Q1 2016 after selling out during the quarter.
  • Independent Portfolio Consultants sold 455 Albany Molecular Research Inc shares in Q1 2016, an estimated $9K.
  • Independent Portfolio Consultants first reported a position in Albany Molecular Research Inc in Q2 2015 and held it in 3 quarters.
  • Independent Portfolio Consultants's Albany Molecular Research Inc position peaked at $9K in Q4 2015.
  • 141 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q1 2016.

Based on Independent Portfolio Consultants's 13F filing for Q1 2016, filed 13 Apr 2016.